AnalystsMarc FrahmMarc Frahm's Stock Forecasts
AnalystsMarc Frahm
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#5177 out of 5510 analysts
Average Return
-18.84%
Win Rate
29%5 out of 17
Risk vs Reward
Poor
Good
Marc Frahm's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dice Therapeutics IncDICE2 | +51.29% | $31.43 | $47.55 | 2023-03-01 - 2023-08-08 | Buy |
Cullinan Therapeutics IncCGEM | +48.66% | $12.70 | $18.88 | 2023-06-15 - 2024-06-14 | Buy |
Incyte CorpINCY | +18.36% | $52.94 | $62.66 | 2024-05-01 - 2025-04-30 | Strong Buy |
Incyte CorpINCY | +18.14% | $103.43 | $122.19 | 2026-01-13 - 2026-09-14 | Strong Buy |
Sana Biotechnology IncSANA | +5.12% | $4.30 | $4.52 | 2025-01-08 - 2026-01-08 | Strong Buy |
Marc Frahm Analyst Color
Get additional color on Marc Frahm's coverage of popular stocks
Marc Frahm's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Puma Biotechnology IncPBYI | 1 | Hold | $6.00 | -34.35% | Maintains | a month ago |
Nuvalent IncNUVL | 2 | Hold | $124.00 | +0.03% | Downgrades | 3 months ago |
Cardiff Oncology IncCRDF | 1 | Hold | N/A | N/A | Downgrades | 3 months ago |
Theravance Biopharma IncTBPH | 3 | Hold | $15.00 | -11.92% | Maintains | 6 months ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 6 months ago |
Incyte CorpINCY | 4 | Strong Buy | $128.00 | +4.75% | Maintains | 8 months ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Cullinan Therapeutics IncCGEM | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Dice Therapeutics IncDICE2 | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 4 years ago |
Xilio Therapeutics IncXLO | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Elevation Oncology IncELEV | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Janux Therapeutics IncJANX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Constellation Pharmaceuticals IncCNST | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Inozyme Pharma IncINZY | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.